Year: 2016
Type: review
Abstract: The advent of native mass spectrometry (MS) in 1990 led to the development of new mass spectrometry instrumentation and methodologies for the analysis of noncovalent protein-ligand complexes. Native MS has matured to become a fast, simple, highly sensitive and automatable technique with well-established utility for fragment-based drug discovery (FBDD). Native MS has the capability to directly detect weak ligand binding to proteins, to determine stoichiometry, relative or absolute binding affinities and specificities. Native MS can be used to delineate ligand-binding sites, to elucidate mechanisms of cooperativity and to study the thermodynamics of binding. This review highlights key attributes of native MS for FBDD campaigns.
Source: Molecules
Authors: Liliana Pedro, Ronald Quinn
Institution: Griffith University
Language: English
Subfield: Spectroscopy
Field: Chemistry
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $3,258
Awards: G1023778219, Developing New Drugs to Eradicate Malaria, G2969617595, Griffith University - to identify potential drugs targeting the vulnerable gametocyte stage or the liver stage of the malaria parasite life cycle, Fragment based screening to deliver drugs targeting tuberculosis and the gametocyte and liver stages of Plasmodium, Mass Spectrometry Instrumentation for Therapeutic Lead Discovery
OpenAlex ID: W2505449729
